IL17A and asthma: Our findings illustrated that in the serum of children with BA, miR‐27a‐3p targets ATF3 and inhibits ATF3 levels, promotes airway inflammation, and upregulates the levels of IL‐17, IL‐6, TNF‐a, and EOS, thereby promoting the occurrence of asthma.